Organs often have fluid-filled spaces called lumens, which are crucial for organ function and serve as transport and delivery ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A fully ...

New digital twin technology that allows a University of Virginia-developed artificial pancreas system to adapt to users’ changing needs – and lets users adjust the settings – has been shown to improve ...

Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the ...

Gut microbes can regulate the exocrine and endocrine functions of the pancreas and hormone production of the gastrointestinal tract, findings that may help develop potential treatments for diabetes ...

Adding advanced artificial intelligence to an artificial pancreas regulating type 1 diabetes is safe and improves the system’s efficiency, a first-of-its-kind study from the University of Virginia ...

Please provide your email address to receive an email when new articles are posted on . The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with type 1 ...

Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...

The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency announced Friday. The pocket-sized system features the the Beta Bionics iLet ACE ...

Camilla Levister, MS, ANP-C, CDCES, a nurse practitioner at the Icahn School of Medicine at Mount Sinai Hospital in New York, gives insight into the nuances of testing closed-loop insulin delivery ...

CARY, N.C.--(BUSINESS WIRE)--Focal Medical, Inc., a privately held, biopharmaceutical company developing novel precision therapeutic products today announced successful completion of the nonclinical ...